Published in Proteomics Clin Appl on November 01, 2010
Oxidative stress as a crucial factor in liver diseases. World J Gastroenterol (2014) 1.04
Alteration in superoxide dismutase 1 causes oxidative stress and p38 MAPK activation following RVFV infection. PLoS One (2011) 0.89
Comparative proteomics study on liver mitochondria of primary biliary cirrhosis mouse model. BMC Gastroenterol (2013) 0.78
Gene expression profiling of HCV genotype 3a initial liver fibrosis and cirrhosis patients using microarray. J Transl Med (2012) 0.78
Oxidative stress response in patients infected by diverse hepatitis C virus genotypes. Hepat Mon (2015) 0.76
Protein signature characterizing Helicobacter pylori strains of patients with autoimmune atrophic gastritis, duodenal ulcer and gastric cancer. Infect Agent Cancer (2017) 0.75
Supplementing Conventional Treatment with Pycnogenol® May Improve Hepatitis C Virus-Associated Type 2 Diabetes: A Mini Review. J Clin Transl Hepatol (2016) 0.75
Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. Blood (2002) 1.58
HCV-associated B cell clonalities in the liver do not carry the t(14;18) chromosomal translocation. Hepatology (2005) 1.57
Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study. Blood (2010) 1.37
Antibody production and in vitro behavior of CD27-defined B-cell subsets: persistent hepatitis C virus infection changes the rules. J Virol (2006) 1.18
Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis C virus. Gastroenterology (2012) 1.12
Extrasalivary lymphoma development in Sjögren's syndrome: clonal evolution from parotid gland lymphoproliferation and role of local triggering. Arthritis Rheum (2003) 1.05
Identification of novel chimpanzee MHC class I and II alleles using an improved sequence-based typing strategy. Hum Immunol (2006) 1.04
Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection. Eur J Immunol (2004) 1.02
Recent prognostic factors in diffuse large B-cell lymphoma indicate NF-kappaB pathway as a target for new therapeutic strategies. Leuk Lymphoma (2008) 0.95
PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage. Mol Med (2010) 0.94
Hepatitis C virus, B-cell proliferation and lymphomas. Leuk Lymphoma (2002) 0.93
Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections. PLoS One (2011) 0.91
Human immunodeficiency virus-associated precursor T-lymphoblastic leukemia/lymphoblastic lymphoma: report of a case and review of the literature. Hum Pathol (2009) 0.91
Pegylated-interferon plus ribavirin for HCV-positive indolent non-Hodgkin lymphomas. Br J Haematol (2009) 0.90
Association of t(14;18) translocation with HCV infection in gastrointestinal MALT lymphomas. J Hepatol (2008) 0.88
Analysis of aberrant somatic hypermutation (SHM) in non-Hodgkin's lymphomas of patients with chronic HCV infection. J Pathol (2005) 0.88
Spontaneous T cell responses to Epstein-Barr virus-encoded BARF1 protein and derived peptides in patients with nasopharyngeal carcinoma: bases for improved immunotherapy. Int J Cancer (2008) 0.87
Detection of bcl-2 rearrangement in mucosa-associated lymphoid tissue lymphomas from patients with hepatitis C virus infection. Haematologica (2004) 0.86
Undifferentiated nasopharyngeal carcinoma from a nonendemic area: protective role of HLA allele products presenting conserved EBV epitopes. Int J Cancer (2009) 0.86
Hepatitis C virus (HCV) I hepatitis C virus (HCV) infection and lymphoproliferative disorders. Front Biosci (2005) 0.84
A novel CDH1 germline missense mutation in a sporadic gastric cancer patient in north-east of Italy. Clin Exp Med (2012) 0.84
IGKV3 proteins as candidate "off-the-shelf" vaccines for kappa-light chain-restricted B-cell non-Hodgkin lymphomas. Clin Cancer Res (2012) 0.83
Low frequency of bcl-2 rearrangement in HCV-associated non-Hodgkin's lymphoma tissue. Leukemia (2003) 0.83
Interferon-based therapy for chronic hepatitis C: current and future perspectives. Hepat Mon (2010) 0.83
KIR/HLA combination associated with the risk of complications in celiac disease. Int J Biol Markers (2011) 0.83
Second primary lymphoma or recurrence: a dilemma solved by VDJ rearrangement analysis. Leuk Lymphoma (2004) 0.83
Elevated B cell-activating factor of the tumour necrosis factor family in coeliac disease. Scand J Gastroenterol (2007) 0.83
Lack of HCV infection in malignant cells refutes the hypothesis of a direct transforming action of the virus in the pathogenesis of HCV-associated B-cell NHLs. Tumori (2002) 0.83
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization. Haematologica (2006) 0.82
Immune signatures in human PBMCs of idiotypic vaccine for HCV-related lymphoproliferative disorders. J Transl Med (2010) 0.82
Mixed cryoglobulinemia syndrome as an additional autoimmune disorder associated with risk for lymphoma development. Blood (2008) 0.81
Sorafenib for the treatment of unresectable hepatocellular carcinoma in HIV-positive patients. Anticancer Drugs (2013) 0.81
Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer. PLoS One (2013) 0.81
HCV-related immunocytoma and type II mixed cryoglobulinemia-associated autoantigens. Ann N Y Acad Sci (2007) 0.80
Application of 2D-DIGE to formalin-fixed diseased tissue samples from hospital repositories: results from four case studies. Proteomics Clin Appl (2013) 0.80
Improving detection of celiac disease patients: a prospective study in iron-deficient blood donors without anemia in north Italy. Eur J Gastroenterol Hepatol (2014) 0.80
Comment re: Ran-GTP control of tumor cell mitosis. Cancer Res (2009) 0.79
Aggressive forms of non-Hodgkin's lymphoma in two patients bearing coinfection of Epstein-Barr and hepatitis C viruses. Int J Oncol (2005) 0.78
Differentiation between non-Hodgkin's lymphoma recurrence and second primary lymphoma by VDJ rearrangement analysis. Br J Haematol (2002) 0.78
Multiparametric analyses of human PBMCs loaded ex vivo with a candidate idiotype vaccine for HCV-related lymphoproliferative disorders. PLoS One (2012) 0.77
Latent membrane protein 1 deletion mutants accumulate in reed-sternberg cells of human immunodeficiency virus-related Hodgkin's lymphoma. J Virol (2005) 0.77
Identification of proteins associated to multi-drug resistance in LoVo human colon cancer cells. Int J Oncol (2009) 0.76
JH6 gene usage among HCV-associated MALT lymphomas harboring t(14;18) translocation. J Immunol (2005) 0.76
Endomicroscopy and cancer: a new approach to the visualization of neoangiogenesis. Gastroenterol Res Pract (2012) 0.76
Two-dimensional gel proteome reference map of human small intestine. Proteome Sci (2009) 0.76
Correction: Genetic Diversity of the KIR/HLA System and Susceptibility to Hepatitis C Virus-Related Diseases. PLoS One (2015) 0.75
2-D gel electrophoresis: constructing 2D-gel proteome reference maps. Methods Mol Biol (2012) 0.75
Evaluation of the suitability of archival Bouin-fixed paraffin-embedded tissue specimens to proteomic investigation. Electrophoresis (2012) 0.75